Acumen hosts Sept 16 Investor Day; no substantive data in 8-K exhibit

Acumen Pharmaceuticals, Inc.

Investor Day held Sept 16, 2026 beginning 10:00 a.m. ET; live webcast hosted by Acumen Pharmaceuticals.
Slide deck posted on IR website after event; Exhibit 99.1 contains title slide only — no results or guidance.
No financial, clinical, or guidance figures disclosed anywhere in this filing; presentation content not included.
Signed by CFO/Chief Business Officer Matthew Zuga; common stock listed on Nasdaq under ABOS.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.